I'm on mobile at the moment. Anyone know how many instruments it would be from ~$1m? It's quite important as labs that now have the instrument are more likely to stay with easyscreen reagents for the foreseeable future - more sales of respiratory, STI, enteric, flavavirus panels etc..If allall $11m of revenue fell within the Q4, SP would've shot up well past $3. Regardless good times ahead
I'm on mobile at the moment. Anyone know how many instruments it...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.040(6.67%) |
Mkt cap ! $127.0M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 60.0¢ | 55.5¢ | $36.10K | 62.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21137 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.5¢ | 26945 | 1 |
View Market Depth
| Last trade - 15.41pm 04/10/2024 (20 minute delay) ? |
| GSS (ASX) Chart |